Fladgate advises WideCells Group PLC on placing
Fladgate has advised WideCells Group PLC, the healthcare services provider to the stem cell industry, on its recent placing to raise gross funds of approximately £750,000. The proceeds will be used to accelerate the roll out of its three stem cell services divisions, CellPlan (the group’s stem cell insurance product), WideCells (the group’s stem cell storage facility at the University of Manchester) and WideAcademy (the group’s educational and resource platform), and further its penetration of the rapidly growing stem cell market.
The Fladgate team was led by capital markets partner Paul Airley.
Accreditations
The legal content provided by Fladgate LLP is for information purposes only and should not be relied on in any specific case without legal or other professional advice.
Copyright is owned by Fladgate LLP and all rights in such copyright are reserved. Material is not to be reproduced in whole or in part without prior written consent.
Fladgate LLP is a limited liability partnership, registered in England and Wales with registered number OC334334. It is authorised and regulated by the Solicitors Regulation Authority, number 484783. The term partner is used to refer to a member of Fladgate LLP. A list of members is available at the registered office shown above.
For more information, please see our Terms of Business and our Personal data processing notice.